Search tips
Search criteria 


Logo of heartHeartVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Heart. 2004 August; 90(8): 827–828.
PMCID: PMC1768393

Will oral antithrombin agents replace warfarin?


The new oral direct thrombin inhibitor ximelagatran is at least equivalent to warfarin for stroke prevention in patients with non-valvar atrial fibrillation, and seems to be a promising adjunct to aspirin after acute coronary syndrome

Keywords: oral antithrombin agents, warfarin, thrombosis, ximelagatran

Articles from Heart are provided here courtesy of BMJ Group